| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4268453 | British Journal of Medical and Surgical Urology | 2011 | 7 Pages |
Abstract
Patients are at significant risk of failure to proceed to adjuvant immunotherapy following CN for mRCC, most commonly due to poor performance status postoperatively. Laparoscopic CN is shown to be safe and effective in well-selected patients. As new targeted treatments for mRCC emerge and their use in combination with CN is evaluated, a detailed and multidisciplinary approach to selection of these patients will continue to be crucial.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Christian Martenstein, Simon Phipps, Ghulam Nabi, Anthony Riddick, Duncan McLaren, Alan McNeill,